Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 865M | 864M | 935M | 864M |
Cost of revenue | 271M | 239M | 291M | 220M |
Gross profit | 594M | 625M | 644M | 644M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 33M | 13M | 20M | 31M |
Other operating expenses | — | — | — | — |
Operating income | 551M | 602M | 614M | 603M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 242M | 235M | 242M | 245M |
Other income expense | — | — | — | — |
Pretax income | -292M | 609M | 71M | 67M |
Tax provision | -141M | 154M | 57M | 50M |
Net income | -151M | 455M | 14M | 17M |
Basic EPS | -0.5 | 1.5 | 0.0 | 0.1 |
Diluted EPS | -0.5 | 1.5 | 0.0 | 0.1 |
Basic average shares | 314.6M | 314.6M | 314.6M | 314.6M |
Diluted average shares | 314.6M | 314.6M | 314.6M | 314.6M |
EBITDA | -73M | 590M | 823M | 498M |
Net income from continuing op. | 594M | 625M | 643M | 644M |
Minority interests | — | — | — | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |